Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shoeb Lallani"'
Autor:
Thomas K. DeLay, James B. Harris, Joseph G. Willis, Shoeb Lallani, Chibuike Obinwa, Ian C. Berg, Alan W. Eberhardt
Publikováno v:
The American Journal of Surgery. 225:667-672
The modern surgeon faces an ever-changing landscape of procedural innovation. The demands of present-day healthcare highlight the importance of successfully developing new medical devices and technologies. This effort requires multidisciplinary colla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52ff11c44c089da8c64239fd7e0693dc
https://doi.org/10.1016/j.amjsurg.2022.11.018
https://doi.org/10.1016/j.amjsurg.2022.11.018
Autor:
Renee D. Read, Jeffrey J. Olson, Stewart G. Neill, Andrew Boucher, Shoeb Lallani, Se-Yeong Oh, Nathaniel H. Boyd, Krishanthan Vigneswaran
Supplementary Figures and Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::555a294465e70801ac9d964c1a08bb17
https://doi.org/10.1158/1078-0432.22478544.v1
https://doi.org/10.1158/1078-0432.22478544.v1
Autor:
Krishanthan Vigneswaran, Shoeb Lallani, Renee Read, Nathaniel H. Boyd, Andrew B. Boucher, Se-Yeong Oh, Stewart G. Neill, Jeffrey J. Olson
Publikováno v:
Clin Cancer Res
Purpose: Glioblastomas (GBMs), neoplasms derived from glia and neuroglial progenitor cells, are the most common and lethal malignant primary brain tumors diagnosed in adults, with a median survival of 14 months. GBM tumorigenicity is often driven by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::996855d7a90a5bd44b77418fe2c7a107
https://doi.org/10.1158/1078-0432.ccr-20-0018
https://doi.org/10.1158/1078-0432.ccr-20-0018
Autor:
Shoeb Lallani, Renee Read, Anna Kenney, Victor Maximov, Michael D. Taylor, M. Hope Robinson, Hamza Farooq
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-15 (2019)
Scientific Reports
Scientific Reports
Medulloblastoma is a malignant pediatric tumor that arises from neural progenitors in the cerebellum. Despite a five-year survival rate of ~70%, nearly all patients incur adverse side effects from current treatment strategies that drastically impact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6e8914bdae78a69ecb7b7b4f46d8554
http://link.springer.com/article/10.1038/s41598-019-50088-1
http://link.springer.com/article/10.1038/s41598-019-50088-1
Autor:
Krishanthan Vigneswaran, Nathaniel H. Boyd, Jeffrey J. Olson, Se-Yeong Oh, Shoeb Lallani, Stewart G. Neill, Renee Read, Andrew B. Boucher
Publikováno v:
Neuro Oncol
Glioblastoma (GBM), neoplasms derived from glia and neuro-glial stem/progenitor cells, are the most common and lethal malignant primary brain tumors diagnosed in adults, with a median survival of 14 months with current treatments. GBM tumorigenicity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb2dc6878c20894475904586b8b1b29a
https://doi.org/10.1093/neuonc/noaa215.381
https://doi.org/10.1093/neuonc/noaa215.381
BACKGROUND: Glioblastomas (GBMs) harbor frequent genetic lesions that include amplification, mutation, and/or over expression of receptor tyrosine kinases (RTKs). Using a novel kinome wide RNAi screen we identified the Hippo kinase pathway and it dow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d135639df0d786c5e9aa7eaf10f4b001
https://europepmc.org/articles/PMC6144077/
https://europepmc.org/articles/PMC6144077/